Generic competition pounds Sanofi-Aventis
Article Abstract:
Second-quarter net profit for French pharmaceutical firm Sanofi-Aventis SA decreased by 6.3% to reach 1.68 bil euro, due in part to competition from generic medications. Net sales dropped 2% to reach 6.94 bil.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Sanofi's profit falls 2.6%
Article Abstract:
First-quarter net profit for pharmaceutical company Sanofi-Aventis S.A. dropped 2.6% to $2.87 bil, while net sales rose by 2%. Sales gains for individual drug products are presented.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Endesa's net profit drops 40% on absence of year-earlier gains. Endesa's earnings jump 88%; holders to decide on rival bids
- Abstracts: Scottish Power posts profit drop, prices lift revenue. E.On's net profit jumps 50% on growth in foreign markets
- Abstracts: Ryanair's posts 26% rise in net amid surging nonticket revenue. Ryanair net drops on high fuel costs
- Abstracts: Finding the most preferred alliance structure between banks and insurance companies. A financial alliance compromise between executives and supervisory authorities
- Abstracts: Nissan's profit plunges 54%: job cuts, new models lead recovery plan; sales target delayed